No association of germline alteration of MSR1 with prostate cancer risk (original) (raw)

Nature Genetics volume 35, pages 128–129 (2003)Cite this article

Abstract

The macrophage scavenger receptor 1 gene (MSR1) was recently identified as a candidate susceptibility gene for hereditary prostate cancer and as a risk factor for sporadic prostate cancer. To confirm these findings, we screened MSR1 for germline mutations among individuals with familial prostate cancer and tested gene variants for associations in both sporadic and familial prostate cancer. Our results do not support MSR1 as a risk factor for prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Wang, L. et al. Am. J. Hum. Genet. 71, 116–123 (2002).
    Article CAS Google Scholar
  2. Xu, J. et al. Nat. Genet. 32, 321–325 (2002).
    Article CAS Google Scholar
  3. Smith, J.R. et al. Science 274, 1371–1374 (1996).
    Article CAS Google Scholar
  4. Xu, J. et al. Am. J. Hum. Genet. 72, 208–212 (2003).
    Article CAS Google Scholar
  5. Ronaghi, M. Genome Res. 11, 3–11 (2001).
    Article CAS Google Scholar
  6. Xu, J. et al. Am. J. Hum. Genet. 69, 341–350 (2001).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank D. Johnson for secretarial support. This study was supported by grants from the Public Health Service, US National Institutes of Health.

Author information

Authors and Affiliations

  1. Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, 920 Hilton Building, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota, USA
    Liang Wang, Julie M Cunningham, Scott Hebbring & Stephen N Thibodeau
  2. Department of Health Sciences Research, Harwick Building, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota, USA
    Shannon K McDonnell, Steven J Jacobsen, James R Cerhan, Susan L Slager & Daniel J Schaid
  3. Department of Urology, 7-130 Gonda Building, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota, USA
    Michael L Blute

Authors

  1. Liang Wang
    You can also search for this author inPubMed Google Scholar
  2. Shannon K McDonnell
    You can also search for this author inPubMed Google Scholar
  3. Julie M Cunningham
    You can also search for this author inPubMed Google Scholar
  4. Scott Hebbring
    You can also search for this author inPubMed Google Scholar
  5. Steven J Jacobsen
    You can also search for this author inPubMed Google Scholar
  6. James R Cerhan
    You can also search for this author inPubMed Google Scholar
  7. Susan L Slager
    You can also search for this author inPubMed Google Scholar
  8. Michael L Blute
    You can also search for this author inPubMed Google Scholar
  9. Daniel J Schaid
    You can also search for this author inPubMed Google Scholar
  10. Stephen N Thibodeau
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toStephen N Thibodeau.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Wang, L., McDonnell, S., Cunningham, J. et al. No association of germline alteration of MSR1 with prostate cancer risk.Nat Genet 35, 128–129 (2003). https://doi.org/10.1038/ng1239

Download citation